A detailed history of Abound Wealth Management transactions in Bio Techne Corp stock. As of the latest transaction made, Abound Wealth Management holds 50 shares of TECH stock, worth $3,797. This represents 0.0% of its overall portfolio holdings.

Number of Shares
50
Previous 50 -0.0%
Holding current value
$3,797
Previous $3.58 Million 11.55%
% of portfolio
0.0%
Previous 0.0%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Aug 08, 2024

SELL
$52.83 - $78.22 $264 - $391
-5 Reduced 9.09%
50 $3.86 Million
Q2 2023

Aug 08, 2024

BUY
$73.76 - $85.98 $368 - $429
5 Added 10.0%
55 $4.49 Million
Q1 2023

Aug 07, 2024

BUY
$71.62 - $86.62 $3,581 - $4,331
50 New
50 $3.71 Million
Q4 2022

Aug 07, 2024

BUY
$80.67 - $352.29 $484 - $2,113
6 Added 300.0%
8 $664,000
Q3 2022

Aug 07, 2024

SELL
$282.54 - $391.85 $13,561 - $18,808
-48 Reduced 96.0%
2 $569,000

Others Institutions Holding TECH

About BIO-TECHNE Corp


  • Ticker TECH
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 39,222,600
  • Market Cap $2.98B
  • Description
  • Bio-Techne Corporation, together with its subsidiaries, develops, manufactures, and sells life science reagents, instruments, and services for the research and clinical diagnostic markets worldwide. The company operates through two segments, Protein Sciences, and Diagnostics and Genomics. The Protein Sciences segment develops and manufactures bi...
More about TECH
Track This Portfolio

Track Abound Wealth Management Portfolio

Follow Abound Wealth Management and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Abound Wealth Management, based on Form 13F filings with the SEC.

News

Stay updated on Abound Wealth Management with notifications on news.